We are live on ! Find out more
HAG

HighPoint Advisor Group Portfolio holdings

AUM $2.84B
1-Year Est. Return 31.94%
This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+31.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$485M
AUM Growth
+$32.9M
Cap. Flow
+$48.9M
Cap. Flow %
10.07%
Top 10 Hldgs %
29.7%
Holding
511
New
21
Increased
214
Reduced
112
Closed
140

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$48.9M
2
CLX icon
Clorox
CLX
+$3.3M
3
MA icon
Mastercard
MA
+$1.51M
4
BA icon
Boeing
BA
+$1.05M
5
ABBV icon
AbbVie
ABBV
+$875K

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$950K
2
ORCL icon
Oracle
ORCL
+$859K
3
FISV
Fiserv Inc
FISV
+$824K
4
HON icon
Honeywell
HON
+$781K
5
CELG
Celgene Corp
CELG
+$779K

Sector Composition

Rank Sector Weight
1 Technology 18.71%
2 Consumer Staples 13.04%
3 Financials 12.7%
4 Healthcare 12.28%
5 Communication Services 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APA icon
351
APA Corp
APA
$13.2B
-5,613
Closed -$137K
APH icon
352
Amphenol
APH
$209B
-5,180
Closed -$132K
AWR icon
353
American States Water
AWR
$3.46B
-1,630
Closed -$138K
BBWI icon
354
Bath & Body Works
BBWI
$4.1B
-7,520
Closed -$107K
BFAM icon
355
Bright Horizons
BFAM
$3.86B
-806
Closed -$115K
BIO icon
356
Bio-Rad Laboratories Class A
BIO
$9.42B
-410
Closed -$144K
BKH icon
357
Black Hills Corp
BKH
$5.69B
-1,882
Closed -$141K
BKR icon
358
Baker Hughes
BKR
$61.1B
-5,011
Closed -$111K
BRKR icon
359
Bruker
BRKR
$8.14B
-2,271
Closed -$108K
BTI icon
360
British American Tobacco
BTI
$128B
-4,145
Closed -$153K
BZUN
361
Baozun
BZUN
$172M
-3,612
Closed -$153K
CBRE icon
362
CBRE Group
CBRE
$42.9B
-2,613
Closed -$143K
CCL icon
363
Carnival Corporation Ltd
CCL
$39.7B
-2,786
Closed -$125K
CIM
364
Chimera Investment
CIM
$1B
-2,292
Closed -$139K
CNS icon
365
Cohen & Steers
CNS
$4.3B
-2,049
Closed -$134K
COR icon
366
Cencora
COR
$61.2B
-4,761
Closed -$409K
CPRT icon
367
Copart
CPRT
$27.5B
-7,376
Closed -$150K
CRL icon
368
Charles River Laboratories
CRL
$12.8B
-887
Closed -$115K
CRSP icon
369
CRISPR Therapeutics
CRSP
$5.17B
-3,400
Closed -$171K
CW icon
370
Curtiss-Wright
CW
$25.5B
-1,000
Closed -$139K
DAL icon
371
Delta Air Lines
DAL
$60.1B
-2,170
Closed -$124K
DLTR icon
372
Dollar Tree
DLTR
$25.2B
-1,819
Closed -$200K
E icon
373
ENI
E
$77.5B
-3,504
Closed -$110K
EIX icon
374
Edison International
EIX
$26.4B
-2,002
Closed -$132K
EMN icon
375
Eastman Chemical
EMN
$8.42B
-1,561
Closed -$130K

Similar funds

HighPoint Advisor Group's Q4 2019 Portfolio in Review

As of Q4 2019, HighPoint Advisor Group held 511 positions worth $485M, up 7.3% from $452M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

HighPoint Advisor Group deployed $48.9M of net new capital in Q4 2019, opening 21 new positions and adding to 214 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 3,195 shares worth $747K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Oracle, an estimated $859K trimmed.

  • HighPoint Advisor Group's largest Q4 2019 buy was Vertex Pharmaceuticals: 3,195 shares worth $747K.
  • HighPoint Advisor Group added most to Berkshire Hathaway Class A in Q4 2019, an estimated $48.9M increase.
  • HighPoint Advisor Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $859K.
  • HighPoint Advisor Group fully exited American International in Q4 2019, selling an estimated $950K.
  • HighPoint Advisor Group's ten largest holdings make up 30% of its $485M portfolio in Q4 2019.
  • HighPoint Advisor Group opened 21 new positions and closed 140 in Q4 2019.
  • HighPoint Advisor Group's portfolio value rose 7.3% quarter-over-quarter to $485M.

Based on HighPoint Advisor Group's 13F filing for Q4 2019, filed 13 Feb 2020.